Laurie Greenberg, MD
Obstetrics & Gynecology · San Diego, CANPI 1265470595
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,002 and has fallen 93.3% since, to $67 in 2025.
Across 218 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$808
- Daiichi Sankyo Inc.$364
- Mayne Pharma Commercial LLC$245
- Bayer$235
- Astellas Pharma US Inc$197
- Shield Therapeutics Inc$176
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,00699%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $808 |
| Daiichi Sankyo Inc. | 21 | $364 |
| Mayne Pharma Commercial LLC | 14 | $245 |
| Bayer | 12 | $235 |
| Astellas Pharma US Inc | 9 | $197 |
| Shield Therapeutics Inc | 8 | $176 |
| Organon | 6 | $167 |
| Aspira Women's Health Inc | 5 | $136 |
| Coopersurgical, Inc. | 7 | $134 |
| Hologic Sales And Service, LLC | 6 | $128 |
| Therapeuticsmd, Inc. | 9 | $127 |
| Exeltis, USA Inc. | 8 | $125 |
| Amgen | 6 | $111 |
| Channel Medsystems, Inc. | 3 | $97 |
| Sumitomo Pharma America, Inc. | 6 | $93 |
| Myovant Sciences Inc. | 5 | $92 |
| Vertical Pharmaceuticals, LLC | 5 | $87 |
| Lilly USA, LLC | 5 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Evofem Biosciences, Inc. | 3 | $66 |
| Pfizer | 4 | $66 |
| Exact Sciences | 4 | $64 |
| Mission Pharmacal Company | 4 | $63 |
| Avion Pharmaceuticals | 4 | $61 |
| Biogen | 2 | $45 |
| Merck | 3 | $42 |
| Lupin Inc. | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Millicent US Inc | 2 | $28 |
| Alfasigma USA, Inc. | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
How this compares
$4,035 in reported general payments places this provider in the 85th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 73 | $5,709 |
| YuvafemEstradiol | 19 | $3,448 |
| Estradiol (Twice Weekly)Estradiol | 30 | $3,089 |
| ProgesteroneProgesterone, Micronized | 43 | $1,369 |
| Clobetasol Propionate | 12 | $284 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Diego
- Antoinette Marengo BarbickSan Diego$69K
- Jeffrey WooSan Diego$31K
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.